wa-law.org > bill > 2025-26 > HB 1520 > Original Bill
The legislature recognizes pharmacists as highly educated health care professionals uniquely qualified to prescribe medications and devices to improve patient outcomes. Being deeply concerned about provider shortages in Washington, particularly in rural and underserved communities, the legislature seeks to expand access to care by leveraging pharmacists' expertise. It is the intent of the legislature to improve patient outcomes for behavioral and physical health by permitting pharmacists to practice at the top of their education, training, and experience.
The definitions in this section apply throughout this chapter unless the context clearly requires otherwise.
Beginning December 1, 2026, a pharmacist may prescribe the following:
Immunizations;
Opioid antagonists and treatments for addiction;
Epinephrine autoinjectors;
Antihistamine agents;
Tobacco cessation products;
Medications to prevent human immunodeficiency virus;
Tuberculin purified protein derivative products;
Hormonal contraception;
Drugs, drug categories, or devices that are limited to conditions that:
Do not require a new diagnosis;
Are minor and generally self-limiting;
Have a test that is used to guide diagnosis or clinical decision making and are waived under the federal clinical laboratory improvement amendments of 1988;
Are devices waived under the federal clinical laboratory improvement amendments of 1988; or
Are prescribed in team-based practices with a shared medical record.
This section expires January 1, 2030.
It shall be unlawful for any person to sell or deliver any legend drug, or knowingly possess any legend drug, or knowingly use any legend drug in a public place, except upon the order or prescription of a physician under chapter 18.71 RCW, an osteopathic physician and surgeon under chapter 18.57 RCW, an optometrist licensed under chapter 18.53 RCW who is certified by the optometry board under RCW 18.53.010, a dentist under chapter 18.32 RCW, a podiatric physician and surgeon under chapter 18.22 RCW, a licensed midwife to the extent authorized under chapter 18.50 RCW, a veterinarian under chapter 18.92 RCW, a commissioned medical or dental officer in the United States armed forces or public health service in the discharge of his or her official duties, a duly licensed physician or dentist employed by the veterans administration in the discharge of his or her official duties, a registered nurse or advanced registered nurse practitioner under chapter 18.79 RCW when authorized by the board of nursing, a pharmacist licensed under chapter 18.64 RCW to the extent permitted under chapter 18.64 RCW, a physician assistant under chapter 18.71A RCW when authorized by the Washington medical commission, or any of the following professionals in any province of Canada that shares a common border with the state of Washington or in any state of the United States: A physician licensed to practice medicine and surgery or a physician licensed to practice osteopathic medicine and surgery, a dentist licensed to practice dentistry, a podiatric physician and surgeon licensed to practice podiatric medicine and surgery, a licensed advanced registered nurse practitioner, a licensed physician assistant, or a veterinarian licensed to practice veterinary medicine: PROVIDED, HOWEVER, That the above provisions shall not apply to sale, delivery, or possession by drug wholesalers or drug manufacturers, or their agents or employees, or to any practitioner acting within the scope of his or her license, or to a common or contract carrier or warehouse operator, or any employee thereof, whose possession of any legend drug is in the usual course of business or employment: PROVIDED FURTHER, That nothing in this chapter or chapter 18.64 RCW shall prevent a family planning clinic that is under contract with the health care authority from selling, delivering, possessing, and dispensing commercially prepackaged oral contraceptives prescribed by authorized, licensed health care practitioners: PROVIDED FURTHER, That nothing in this chapter prohibits possession or delivery of legend drugs by an authorized collector or other person participating in the operation of a drug take-back program authorized in chapter 69.48 RCW.
[Empty]
A violation of this section involving the sale, delivery, or possession with intent to sell or deliver is a class B felony punishable according to chapter 9A.20 RCW.
A violation of this section involving knowing possession is a misdemeanor. The prosecutor is encouraged to divert such cases for assessment, treatment, or other services.
A violation of this section involving knowing use in a public place is a misdemeanor. The prosecutor is encouraged to divert such cases for assessment, treatment, or other services.
No person may be charged with both knowing possession and knowing use in a public place under this section relating to the same course of conduct.
In lieu of jail booking and referral to the prosecutor for a violation of this section involving knowing possession, or knowing use in a public place, law enforcement is encouraged to offer a referral to assessment and services available under RCW 10.31.110 or other program or entity responsible for receiving referrals in lieu of legal system involvement, which may include, but are not limited to, arrest and jail alternative programs established under RCW 36.28A.450, law enforcement assisted diversion programs established under RCW 71.24.589, and the recovery navigator program established under RCW 71.24.115.
For the purposes of this section, "public place" has the same meaning as defined in RCW 66.04.010, but the exclusions in RCW 66.04.011 do not apply.
For the purposes of this section, "use any legend drug" means to introduce the drug into the human body by injection, inhalation, ingestion, or any other means.
The pharmacy quality assurance commission may adopt rules to administer and implement this act.